These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7394864)

  • 21. Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.
    Giorgi O; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):14-8. PubMed ID: 7329448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucose on recovery of energy metabolism following hypoxia-oligemia in mouse brain: dose-dependence and carbohydrate specificity.
    Welsh FA; Sims RE; McKee AE
    J Cereb Blood Flow Metab; 1983 Dec; 3(4):486-92. PubMed ID: 6630318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-butyrolactone (GBL) disruption of passive avoidance learning in the day-old chick appears to be due to its effect on GABAB not gamma-hydroxybutyric [corrected] acid (GHB) receptors.
    Sherry JM; Hazi A; Hale MW; Milsome SL; Crowe SF
    Behav Brain Res; 2009 Feb; 197(2):347-55. PubMed ID: 18948143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
    Towiwat P; Phattanarudee S; Maher TJ
    Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of naftidrofuryl on high energy phosphates, glycogen, lactate and pyruvate in mouse hearts during asphyxia and post-asphyctic recovery.
    Estler CJ; Böcker R; Schinzel W
    Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):39-42. PubMed ID: 7447560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of the interconversion of gamma-butyrolactone (GBL) to gamma hydroxybutyric acid (GHB) by Raman spectroscopy.
    Munshi T; Brewster VL; Edwards HG; Hargreaves MD; Jilani SK; Scowen IJ
    Drug Test Anal; 2013 Aug; 5(8):678-82. PubMed ID: 23225646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential alterations of cerebral carbohydrate metabolism associated with gamma-hydroxybutyrate.
    Macmillan V
    Brain Res; 1980 Feb; 183(1):123-34. PubMed ID: 7357398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential in vivo measurement of cerebral intracellular metabolites with phosphorus-31 magnetic resonance spectroscopy during global cerebral ischemia and reperfusion in rats.
    Andrews BT; Weinstein PR; Keniry M; Pereira B
    Neurosurgery; 1987 Nov; 21(5):699-708. PubMed ID: 3696405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS.
    LeBeau MA; Montgomery MA; Miller ML; Burmeister SG
    J Anal Toxicol; 2000 Sep; 24(6):421-8. PubMed ID: 10999347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
    van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
    Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high vs. low arterial blood oxygen content on cerebral energy metabolite levels during hypoxia with normothermia and hypothermia in the rat.
    Keykhah MM; Hägerdal M; Welsh FA; Barrer MA; Sisco F; Harp JR
    Anesthesiology; 1980 Jun; 52(6):492-5. PubMed ID: 6769365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of acute carbon monoxide intoxication on the cerebral energy metabolism of the rat.
    MacMillan V
    Can J Physiol Pharmacol; 1975 Jun; 53(3):354-62. PubMed ID: 1148922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation pathways of gamma-butyrolactone from the furan ring of tegafur during its conversion to 5-fluorouracil.
    Yamamiya I; Yoshisue K; Matsushima E; Nagayama S
    Drug Metab Dispos; 2010 Aug; 38(8):1267-76. PubMed ID: 20463005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A color test for rapid screening of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in drink and urine].
    Zhang SY; Huang ZP
    Fa Yi Xue Za Zhi; 2006 Dec; 22(6):424-7. PubMed ID: 17285863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropharmacological profile of tetrahydrofuran in mice.
    Werawattanachai N; Towiwat P; Unchern S; Maher TJ
    Life Sci; 2007 Apr; 80(18):1656-63. PubMed ID: 17331547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reactivity of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic solutions.
    Hennessy SA; Moane SM; McDermott SD
    J Forensic Sci; 2004 Nov; 49(6):1220-9. PubMed ID: 15568693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of different degrees of brain ischemia and tissue lactic acidosis on the short-term recovery of neurophysiologic and metabolic variables.
    Rehncrona S; Rosén I; Smith ML
    Exp Neurol; 1985 Mar; 87(3):458-73. PubMed ID: 3972049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.